A METHOD FOR PREDICTING THE PRESENCE OF BENIGN PROSTATE HYPERPLASIA OR PROSTATE CANCER

Claims

A method for predicting the presence of benign prostatic hyperplasia or prostate cancer, including determining the serum concentration of prostate-specific antigen and performing ultrasound imaging of the prostate gland, characterized in that the level of male sexuality in patients is determined in points using an integrated sexuality assessment questionnaire (Rostov questionnaire), and the volume of the prostate gland in cm is determined using ultrasound imaging. 3 , and also measure the serum concentration of prostate-specific antigen in ng / ml; with a concentration of prostate-specific antigen above 4.25 ng / ml, a sexuality level of less than 63 points and a prostate volume of less than 50 cm 3Patients are most likely to have prostate cancer if their prostate-specific antigen concentration is below 4.25 ng / ml, their sexuality level is above 63 points, and their prostate volume is greater than 50 cm 3 Patients are most likely to have benign prostatic hyperplasia.